To Evaluate the Pharmacokinetic Effects of TQD3606 for Injection in Healthy Adult Subjects

NCT05340530 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections

Interventions

DRUG: The injectable TQD3606
DRUG: meropenem
DRUG: Avibactam Sodium
DRUG: Placebo

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.